RecruitingNCT05020626

Modelling Tau Distribution From DTI With Generative Adversarial Network for Alzheimer's Disease Diagnosis

Modelling Tau Deposition and Distribution From Diffusion Tensor Imaging With Generative Adversarial Network for Alzheimer's Disease Diagnosis


Sponsor

Chinese University of Hong Kong

Enrollment

250 participants

Start Date

Jun 30, 2021

Study Type

OBSERVATIONAL

Conditions

Summary

The most significant impact of this project is to propose for the first time a novel generative adversarial network (GAN), as one kind of deep learning architecture, to automatically generate synthetic PET images reflecting tau deposition, from brain DTI images. If successful, this framework will become the most state-of-the-art approach to simulate the stereotypical pattern of intracerebral tau accumulation and distribution in vivo. Synthetic tau-PET images via DTI, possessing overwhelming superiority in radiation-free, non-invasiveness and cost-effectiveness, will potentially serve as one of alternative modalities of PET in detecting tau-load and probably outperform PET on accessibility, generalizability, and availability in future, making it much more attractive in clinical application. A big conceptual shift may occur preferring a fire-new tau-PET simulated via DTI. The DTI data-driven deep learning framework to be created in this project will constitute an accurate, robust, clinically applicable and explainable tool to efficiently categorize the subjects into tau-burden positive and tau-burden negative cases, which will undoubtedly contribute to both clinical and research activities.


Eligibility

Min Age: 55 Years

Plain Language Summary

Simplified for easier understanding

This study uses artificial intelligence (AI) to model the distribution of tau protein — a hallmark of Alzheimer's disease — using standard brain MRI scans, potentially allowing diagnosis without the need for specialized PET scans. **You may be eligible if...** - You are 55 years or older - You have had a brain MRI taken within 6 months of a confirmed diagnosis of Alzheimer's disease, mild cognitive impairment (MCI), or normal cognition **You may NOT be eligible if...** - You have Alzheimer's mixed with another type of dementia - You have a non-Alzheimer's type of dementia - You have a history of severe traumatic brain injury, severe depression, stroke, brain tumors, or a major systemic illness Talk to your doctor to see if this trial is right for you.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.


Locations(1)

The Chinese University of Hong Kong, Prince of Wale Hospital

Hong Kong, Shatin, Hong Kong

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT05020626